Taboola script Diabled on 7th April on request Adpushup head code Diabled on 7th April on request

AIIMS Medical Team To Examine Jayalalithaa  

6 Oct, 2016 09:57 IST|Sakshi
Chief Minister Jayalalithaa was admitted to Apollo Hospitals on September 22 for fever and dehydration

Chennai: A three-member doctors team from All India Institute of Medical Sciences (AIIMS) will examine Tamil Nadu Chief Minister J.Jayalalithaa admitted in Apollo Hospital since last month, said reports.

According to reports, the three-member team - pulmonologist G.C.Khilnani, cardiologist Nitish Naik and anaesthetist Anjan Trikha will examine the 68-year-old Jayalalithaa. However, officials of Apollo Hospitals and the state government were not available to comment.

The AIIMS medical team comes after a British doctor Richard Beale, consultant in Intensive Care Medicine at Guy's and St.Thomas Hospital, London examined Jayalalithaa. According to Apollo Hospitals, the treatment plan was based on detailed discussions with Beale.

While Apollo Hospitals initially said Jayalalithaa was cured of fever, later it said she was being treated for infection. She was advised some more days stay in the hospital

The treatment plan included appropriate antibiotics, respiratory support and other allied clinical measures presently being continued to treat the infection.

Jayalalithaa was admitted to Apollo Hospitals on September 22 for fever and dehydration.

While Apollo Hospitals initially said Jayalalithaa was cured of fever, later it said she was being treated for infection. She was advised some more days stay in the hospital.

Meanwhile, the Madras High Court on October 4 directed Tamil Nadu's Additional Advocate General to get instructions from the government on Jayalalithaa's health.

Social activist Traffic Ramaswamy filed a public interest litigation (PIL) in the Madras High Court seeking the real status of Jayalalithaa's health.

The court also observed that people were anxious to know about the chief minister's health.

IANS

whatsapp channel
Read More:
More News